Qube Research & Technologies (QRT)
THC icon

Qube Research & Technologies (QRT)’s Tenet Healthcare THC Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio THC Stock Details THC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$13.5M Sell
72,008
-581,324
-89% -$107M 0.01% 1118
2026
Q1 		$123M Buy
653,332
+499,399
+324% +$105M 0.14% 177
2025
Q4 		$30.6M Buy
153,933
+146,804
+2,059% +$29.7M 0.03% 711
2025
Q3 		$1.45M Buy
+7,129
New +$1.26M ﹤0.01% 2377
2025
Q2 		– Sell
-243,561
Closed -$32.8M – 3973
2025
Q1 		$32.8M Sell
243,561
-1,165,529
-83% -$153M 0.04% 548
2024
Q4 		$178M Buy
1,409,090
+554,680
+65% +$82.5M 0.23% 87
2024
Q3 		$142M Buy
854,410
+368,533
+76% +$55.7M 0.21% 93
2024
Q2 		$64.6M Buy
485,877
+310,138
+176% +$37.3M 0.1% 224
2024
Q1 		$18.5M Buy
175,739
+4,703
+3% +$423K 0.03% 594
2023
Q4 		$12.9M Buy
171,036
+77,214
+82% +$4.89M 0.03% 642
2023
Q3 		$6.18M Buy
+93,822
New +$7.01M 0.02% 840
2021
Q3 		– Sell
-5,453
Closed -$365K – 2767
2021
Q2 		$365K Sell
5,453
-2,950
-35% -$183K ﹤0.01% 1455
2021
Q1 		$437K Sell
8,403
-11,422
-58% -$577K 0.01% 1252
2020
Q4 		$792K Buy
+19,825
New +$640K 0.01% 952
2020
Q3 		– Sell
-18,315
Closed -$332K – 2104
2020
Q2 		$332K Buy
+18,315
New +$361K ﹤0.01% 1256
2020
Q1 		– Sell
-25,472
Closed -$969K – 1656
2019
Q4 		$969K Buy
+25,472
New +$763K 0.03% 626
2018
Q4 		– Sell
-3,999
Closed -$114K – 838
2018
Q3 		$114K Buy
3,999
+2,231
+126% +$73.7K 0.02% 715
2018
Q2 		$59K Buy
+1,768
New +$55K 0.04% 458

Other funds holding THC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GCM
Glenview Capital Management New York $5.49B AUM 46.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Qube Research & Technologies (QRT)'s THC Position: Q2 2026 in Review

Qube Research & Technologies (QRT) reduced its Tenet Healthcare (THC) stake by 89% in Q2 2026, selling an estimated $107M and leaving 72,008 shares worth $13.5M. The position accounts for 0.01% of the portfolio, ranked #1118.

Qube Research & Technologies (QRT) first reported a position in THC in Q2 2018 and has held it in 18 quarters since. The position peaked at $178M in Q4 2024. 678 funds tracked by Wall St. Rank hold THC as of Q2 2026.

  • Qube Research & Technologies (QRT) held 72,008 shares of Tenet Healthcare worth $13.5M as of Q2 2026.
  • Qube Research & Technologies (QRT) sold 581,324 Tenet Healthcare shares in Q2 2026, an estimated $107M.
  • Tenet Healthcare made up 0.01% of Qube Research & Technologies (QRT)'s portfolio in Q2 2026, its #1118 holding.
  • Qube Research & Technologies (QRT) first reported a position in Tenet Healthcare in Q2 2018 and has held it in 18 quarters since.
  • Qube Research & Technologies (QRT)'s Tenet Healthcare position peaked at $178M in Q4 2024.
  • 678 funds tracked by Wall St. Rank held Tenet Healthcare as of Q2 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2026, filed 14 Aug 2026.